- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 254
JW Therapeutics to jump to public markets
The immuno-oncology company – co-founded by Juno Therapeutics, a spinout of several institutions – is reportedly seeking $250m to $300m in a Hong Kong offering.
Aug 18, 2020Mobilion roars home to $35m series B
PNNL's biomolecule analysis equipment spinout Mobilion Systems will use the funding for recruitment aimed at driving its product roadmap.
Aug 18, 2020JW Therapeutics to jump to public markets
WuXi AppTec and Juno Therapeutics' immuno-oncology joint venture is reportedly seeking $250m to $300m in a Hong Kong offering.
Aug 18, 2020Mobilion roars to $35m series B
Agilent returned for a round that pushed the medical device developer's overall funding past the $50m mark and which will go to commercialising its Slim technology.
Aug 18, 2020Thirty Madison counts up $47m
Johnson & Johnson Innovation – JJDC participated in a round that boosted the total raised by the hair loss, migraine and acid reflux treatment provider to $70m.
Aug 18, 2020Investors dispense $32m to Practo
The medical booking management app was reportedly valued at $310m following the round, which was led by AIA and which included Tencent and Alphabet.
Aug 18, 2020Aikangte sees out funding boost
Fosun Capital is among the investors that have backed $14.4m in series A and A-plus rounds for the eyecare equipment maker which will fund research and development efforts.
Aug 17, 2020Daily deal net: August 17, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Aug 17, 2020Nano-X plans $106m IPO target
Existing investors including Foxconn, SK Telecom and iA Financial could buy up to $80m of shares in the medical imaging system developer's initial public offering.
Aug 17, 2020Mission Bio accomplishes $70m series C
UCSF spinout Mission Bio has pushed its overall funding to more than $120m following a series C round led by Novo Growth.
Aug 17, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


